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Hyperbilirubinaemia after major thoracic surgery:
comparison between open-heart surgery and oesophagectomy
Kikumi K Hosotsubo, Masaji Nishimura and Shinya Nishimura
Osaka University Hospital, Suita, Japan
Abstract
Background: Hyperbilirubinaemia is a common occurrence in patients who are admitted to
intensive care units (ICUs) after major surgery, and it is associated with high mortality. We
investigated the incidence of hyperbilirubinaemia after two major types of thoracic surgery:
open-heart surgery and oesophagectomy. In order to identify the risk factors associated with
hyperbilirubinaemia after major surgery, we compared the incidence after open-heart surgery
with that after oesophagectomy.
Results: Hyperbilirubinaemia was detected in 51% of the open-heart surgery patients
(n=133) and in 64% in the oesophagectomy group (n=74). The incidence of
hyperbilirubinaemia was significantly related to the duration of surgery (P<0.05). In the
open-heart surgery group, duration of surgery was 465±24 min for the patients without
hyperbilirubinaemia and 571±26 min for the patients with hyperbilirubinaemia. In the
oesophagectomy group, the procedure durations were 415±17 min and 493±20 min,
respectively. The overall mortality rate was 8% in the open-heart surgery group; the rate was
12% in those with hyperbilirubinaemia, but 5% in those without hyperbilirubinaemia. No
members of the oesophagectomy group died, with or without hyperbilirubinaemia. Infection
significantly affected both the occurrence of hyperbilirubinaemia and mortality in the open-
heart surgery group. In the subgroups from the open-heart surgery group, 5% (three out of
65) of those without hyperbilirubinaemia (or evidence of infection) died; of the patients with
hyperbilirubinaemia, 3% (one out of 38) of those without infection died and 23% (seven out
of 30) with detected infection died.
Conclusion: After open-heart surgery and oesophagectomy, approximately half of the
patients studied had higher levels of serum total bilirubin. Time spent in surgery was
significantly related to the occurrence of hyperbilirubinaemia. Infection significantly affected
mortality and total bilirubin levels after open-heart surgery. Control of infection plays a crucial
role in the prevention of hyperbilirubinaemia and in reducing mortality.
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Researchers have reported rates of hyperbilirubinaemia
after cardiac operations involving cardiopulmonary bypass
(CPB) that range from approximately 5% [1] to 20% or
even as high as 40% [2]. Hypoperfusion, haemodilution
and other factors that reduce the delivery of oxygen to the
liver or increase the bilirubin load are thought to cause
postoperative hyperbilirubinaemia. Most reports, however,
have been on patients who have undergone open-heart
surgery, and the effect of CPB may be a contributory
factor. It has not been determined whether CPB itself, tho-
racotomy, or surgical invasion of the body increases the
incidence of postoperative hyperbilirubinaemia. There is
little data from which to judge whether CPB itself is a
major factor, or whether other factors induce hyperbilirubi-
naemia. On the other hand, oesophagectomy is one of the
most invasive thoracic surgeries, and hyperbilirubinaemia
is detected more frequently after oesophagectomy than
after other operations [3,4].
Hyperbilirubinaemia also frequently accompanies sepsis,
which is correlated with mortality [5,6]. Infection is the most
common complication after surgery, and it is therefore pos-
sible that, in addition to operative factors, postoperative
infection may also contribute to the development of hyper-
bilirubinaemia after major surgery. The effect of postopera-
tive infection on the development of hyperbilirubinaemia has
not yet been systematically investigated, however. In the
present study, we compared the incidence of hyperbilirubi-
naemia in patients after cardiac surgery and oesophagec-
tomy in order to evaluate whether CPB was related to
postoperative hyperbilirubinaemia. In addition, we investi-
gated the extent to which the presence of infection was
related to the development of hyperbilirubinaemia. Patients
who develop hyperbilirubinaemia require longer stays in the
ICU, which frustrates attempts to expedite the recovery of
patients [7]. In order to prevent its development, it is impor-
tant to know the risk factors for hyperbilirubinaemia.
The purpose of the present study was to examine the inci-
dence and nature of postoperative hyperbilirubinaemia in
patients undergoing different kinds of thoracic operations,
to identify the perioperative and surgical risk factors asso-
ciated with postoperative hyperbilirubinaemia, and to
determine how postoperative hyperbilirubinaemia is
related to mortality and morbidity.
Patients and methods
We retrospectively investigated 207 adult patients (all
older than 18 years) who had been admitted to our ICU
during the 2-year period from March 1996 to February
1998 following a major operative procedure. Of the
patients studied, 133 had undergone open-heart surgery
(C group) and 74 had undergone oesophagectomy
(E group). We chose these two types of surgery because
both are highly invasive of the thorax. The operations of all
of the C group patients involved CPB, so comparing data
from these patients with those from patients subjected to
similarly invasive surgery without CPB may shed some
light on the effect of CPB on postoperative hyperbilirubi-
naemia. Most of the patients in the C group were anaes-
thetized with narcotics. In the C group, 51 patients had
coronary artery disease, 64 valvular diseases and 18 had
a thoracic aortic aneurysm. All of the patients in the
E group had oesophageal cancer. They were anaes-
thetized with isoflurane or propofol. No patients in either
group showed any preoperative clinical signs of bacterial
infection except for a single patient in the C group.
Preoperative venous blood samples were subjected to
biochemical analysis for hepatobiliary function and identifi-
cation of hepatitis viruses. After the operation, blood was
drawn from arterial lines for biochemical analysis. Blood
samples were analyzed for concentrations of total bilirubin
(TB), conjugated bilirubin, unconjugated bilirubin, alanine
aminotransferase, asparate aminotransferase, lactate
dehydrogenase and alkaline phosphatase. Blood samples
were obtained on postoperative days (PODs) 1, 2, 3, 5, 7,
9, 11 and 14. Postoperative hyperbilirubinaemia was
defined as TB concentrations over 2 mg/dl within 14 days
after the operation.
To provide evidence of infection, blood samples were also
analyzed for C-reactive protein (CRP) and white blood
cells (WBCs). When infection was suspected, samples
were tested for circulating endotoxin, β-glucan and
Candida protein antigens. Patients were routinely moni-
tored for infection using clinical judgement and data for
CRP and WBCs. Perioperative infection was considered
present when at least one of following three conditions
was fulfilled: WBC greater than 12 000/µl and body tem-
perature greater than 38°C or less than 36°C; the same
species of bacteria was detected from two different sites;
and endotoxin greater than 5 pg/ml and β-glucan greater
than 50 pg/ml, or positive Candida protein antigens. Bio-
chemical analysis (TB, conjugated bilirubin, unconjugated
bilirubin, CRP and liver enzymes) was performed using an
automated analyzer (COBAS MIRA Plus; Japan Roche,
Tokyo, Japan). Hepatitis viruses were detected using
immunoassay (hepatitis B virus – Counting Immunoassay
Sysmex Runream, Toa Medical Electron, Kobe, Japan;
hepatitis C virus – ELISA Test III, Ortho-Clinical Diagnos-
tics, Tokyo, Japan). Endotoxin and β-glucan were mea-
sured using commercially available chromogenic assays
(Endospecy ES and Toxicolor System LS; Seikagaku
Industries Corporation, Tokyo, Japan). A Candida detec-
tion system that employs latex agglutination (Ramco Labo-
ratories, Houston, TX, USA) was used to test for Candida
protein antigens. In order to identify the presence of fungal
infection, β-glucan and Candida protein antigens were
measured. The results of these tests were collated by
reviewing the ICU laboratory data sheets.
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The surgical factors investigated, by reviewing anesthesia
records, were operative time and volume of blood trans-
fused. All patients were tracked for at least 1 month after
the operation to evaluate postoperative mortality.
Statistical analysis
Data are expressed as mean ± standard error of the mean.
Multiple comparisons were performed using analysis of
varience. Patients’ characteristics were compared using
Scheffe’s test for continuous variables (preoperative liver
enzymes, TB, conjugated bilirubin, operative time and
volume of blood transfused). In the subgroups of the
patients with hyperbilirubinaemia and without hyperbilirubi-
naemia, Scheffe’s test was used for continuous variables
(TB, CRP, WBCs) on each POD. Duration of stay in ICU
was compared using Wilcoxon’s test. For categorical vari-
ables (sex, existence of hyperbilirubinaemia, bacterial
infection, type of surgical procedure), χ2 analyses were
performed. Fisher’s test was used to compare the mortal-
ity between the C and the E groups. P < 0.05 was consid-
ered statistically significant.
Results
Table 1 shows the demographic characteristics of the
patients, along with preoperative data for biochemistry of
hepatobiliary function, presence of hepatitis viruses, oper-
ative time and volume of blood transfused for each group
of patients. Except for the male:female ratio, the baseline
characteristics of the 207 patients in the study were
similar for both groups. The higher proportion of male
patients in the oesophagectomy group (E group) reflects
the generally higher occurrence of oesophageal cancer in
males. In the open-heart surgery group (C group), 13
patients were positive for hepatitis C virus and two had
hyperbilirubinaemia. In the E group, seven patients were
positive for hepatitis C virus and none had hyperbilirubi-
naemia. Only one patient was a carrier of hepatitis B virus
in the C group, and this patient did not show liver dysfunc-
tion either before or after the operation. The mean age
was similar in the both groups. The liver function tests of
all patients were within the normal range, and the value for
serum bilirubin and duration of operation did not differ sig-
nificantly between the groups. Patients in the C group
received larger volumes of transfused blood during
surgery than did those in the E group (Table 2).
Incidence and nature of hyperbilirubinaemia
Postoperative hyperbilirubinaemia was detected in 56%
(115 out of 207) of the patients in the two groups com-
bined. It was present in 51% of the C group patients and
in 64% of the E group patients. The incidence of hyper-
bilirubinaemia did not differ significantly between the
groups, and it did not vary according to the procedures
used in the C group (Table 3). In patients without hyper-
bilirubinaemia, TB levels peaked on POD 1 (1.3±0.09 mg/dl
in the C group, and 1.2 ± 0.06 mg/dl in the E group), and
then decreased gradually to preoperative values by
POD 7. In patients with hyperbilirubinaemia, TB levels
remained above the normal range even by POD 14. In
patients with hyperbilirubinaemia in the C group, TB levels
increased toward peak values on POD 11; in patients with
hyperbilirubinaemia in the E group, TB levels peaked on
POD 5 and then gradually decreased (Fig. 1).
Incidence of postoperative infection and
hyperbilirubinaemia
CRP values increased significantly on POD 1, peaked on
POD 2 or 3, and then decreased gradually. WBC values
also increased significantly after surgery. In the E group
WBC values showed a biphasic pattern, the first peak
occurring on POD 2 and the second on PODs 9–11. In
the C group 24% (32 out of 133) and in the E group 55%
(41 out of 74) of patients met the criteria for infection.
These infected patients showed significantly increased
incidence of hyperbilirubinaemia: 94% (30 out of 32) of
patients in the C group and 85% (35 out of 41) of patients
in the E group. Postoperative infection correlated with
serum TB levels in patients with hyperbilirubinaemia. In the
C group, TB values in patients without infection peaked on
POD 3 (2.9 ± 0.37 mg/dl) and then decreased. In the
E group, TB values for infected patients exhibited a bipha-
sic pattern; after a postoperative increase, TB levels
decreased before rising to hit peak values (3.0±0.35 mg/dl)
on POD 5 (Fig. 2).
Table 1
Preoperative characteristics
C group E group
n 133 74
Sex (male/female) 78/55* 56/18
Age (years) 60.0 ± 1.3 58.9 ± 1.3
Hyperbilirubinaemia 2 0
Hepatitis C virus positive 13 7
Bacterial infection 1 0
Total bilirubin (mg/dl) 0.8 ± 0.06 0.7 ± 0.05
Conjugated bilirubin (mg/dl) 0.2 ± 0.02 0.2 ± 0.01
Alanine aminotransferase (IU/l) 18 ± 1.9 19 ± 2.7
Aspartate aminotransferase (IU/l) 19 ± 1.9 23 ± 1.8
Lactate dehydrogenase (IU/l) 321 ± 28.8 246 ± 15.0
Alkaline phophatase (IU/l) 122 ± 7.2 118 ± 6.0
CRP (mg/dl) 0.5 ± 0.36 0.6 ± 0.39
WBC count (cells/mm3) 6532 ± 574 5799 ± 366
Patients in group C were subjected to open-heart surgery; patients in
group E were subjected to oesophagectomy. Data are expressed as
mean ± standard error. *P < 0.05, versus group E patients.
For patients who had both hyperbilirubinaemia and post-
operative infection in C and E groups, peaks of TB value
were 8.5±2.49 mg/dl in the C group and 3.4±0.23 mg/dl
in the E group, which occurred on PODs 11 and 5,
respectively. In both groups, postoperative infection corre-
lated closely with the development of hyperbilirubinaemia.
Risk factors for hyperbilirubinaemia
Table 4 shows the factors that were considered to be
related to the development of hyperbilirubinaemia. In both
groups, patients with hyperbilirubinaemia were in surgery
for significantly longer than those without. In the C group,
preoperative concentration of serum bilirubin also corre-
lated with postoperative hyperbilirubinaemia. Liver enzyme
data did not differ significantly between the patients with
and without hyperbilirubinaemia.
Mortality and morbidity
The overall mortality rate was 8% in the C group; mortality
was 12% in those with hyperbilirubinaemia and 5% in
those without it. None of the E group patients died, with or
without hyperbilirubinaemia. Infection significantly corre-
lated with both the occurrence of hyperbilirubinaemia and
mortality in the C group. In the subgroups of patients from
group C, 5% (three out of 65) of those without hyperbiliru-
binaemia (or evidence of infection) died; in the patients
with hyperbilirubinaemia, 3% (one out of 38) of those
without infection died and 23% (seven out of 30) with
detected infection died (Table 5). In both groups, patients
without hyperbilirubinaemia left the ICU sooner than those
with hyperbilirubinaemia (Table 6).
Discussion
The present study found that hyperbilirubinaemia devel-
oped in 56% of patients in the ICU who had undergone
open-heart surgery or oesophagectomy; that infection
during the perioperative period correlated with the devel-
opment of hyperbilirubinaemia; that other risk factors for
hyperbilirubinaemia were operative time and volume of
blood transfused during surgery; and that in the open-
heart surgery group (C group) mortality was significantly
higher for patients with hyperbilirubinaemia than for those
without it.
The study presents for the first time comparative results
regarding the development of postoperative hyperbilirubi-
naemia after two types of major thoracic operation. Other
authors have reported the incidence of hyperbilirubi-
naemia after heart operations with CPB or have investi-
gated the risk factors for hyperbilirubinaemia after cardiac




C group E group
Operative time (min) 517 ± 25 464 ± 19
Transfused volume of blood (ml) 2711 ± 353* 663 ± 154
Total bilirubin (mg/dl) 3.3 ± 0.68 3.0 ± 0.26
Conjugated bilirubin (mg/dl) 1.4 ± 0.35 1.1 ± 0.13
Alanine aminotransferase (IU/l) 19 ± 2.2 19 ± 2.6
Aspartate aminotransferase (IU/l) 23 ± 2.2 23 ± 2.1
Lactate dehydrogenase (IU/l) 340 ± 34.6 249 ± 17.8
Alkaline phosphatase (IU/l) 128 ± 7.8 120 ± 5.7
CRP (mg/dl) 17.5 ± 1.14 21.7 ± 1.32
WBC count (cells/mm3) 11 369 ± 597 10 958 ± 654
Number of patients with hypotension 27 8
(SBP < 80 mmHg)
Hypoxia (arterial oxygen tension 0 0
< 60 mmHg)
CRP (mg/dl) 0.5 ± 0.36 0.6 ± 0.39
Use of vasopressors 127 58
Isolated organisms
Gram-positive bacteria 19 12
Gram-negative bacteria 24* 31
Fungi 11* 1
Biochemical tests
Endotoxin (> 5 pg/ml) 28 32
β-glucan (> 50 pg/ml) 10* 1
Antibiotics 94* 71
Antifungal agents 10 1
Tube feeding 6* 36
Patients in group C were subjected to open-heart surgery; patients in
group E were subjected to oesophagectomy. Data are expressed as
mean ± standard error. The maximum values of TB, conjugated
bilirubin, alanine aminotransferase, aspartate amintransferase, lactate
dehydrogenase, alkaline phosphatase, CRP and WBC after operation
are shown. *P < 0.05 versus patients in group E. SBP, systolic blood
pressure.
Table 3




Cardiac surgery 133 68 (51)
Coronary artery bypass grafting 51 22 (43)
Valvular procedures 64 37 (58)
Aneurysm 18 9 (50)
Oesophagectomy 74 47 (64)
No significant differences in the incidence of hyperbilirubinaemia were
observed between the surgical procedures.
bilirubinaemia after open-heart surgery and oesophagec-
tomy. This comparison is helpful in evaluating the co-
occurrence of CPB with hyperbilirubinaemia after surgery.
The incidence of hyperbilirubinaemia in the patients
studied was generally higher than the rates reported by
other authors. Wang et al [2] pointed out that, despite a
decade of advance in CPB and anaesthesia techniques,
the incidence of hyperbilirubinaemia after cardiac opera-
tions with CPB did not decrease. Various reasons have
been advanced to explain the development of postopera-
tive hyperbilirubinaemia. The present study clearly shows
that the longer the operative time and the larger the
volume of blood transfused, the higher the incidence of
postoperative hyperbilirubinaemia. The patients in this
study spent longer times in the operation room than those
in other reports; this may be one of the reasons why the
incidence of hyperbilirubinaemia was comparatively high.
The incidence of hyperbilirubinaemia did not differ signifi-
cantly between the C and E groups, and neither did opera-
tive time. If CPB per se is connected to the development
of hyperbilirubinaemia, the incidence of hyperbilirubi-
naemia would have been higher in the C than in the
E group. The present results show no difference between
the groups, however, which would suggest that CPB is
not a major factor in the postoperative development of
hyperbilirubinaemia.
We also evaluated the effect of bacterial infection on the
development of hyperbilirubinaemia. Bacterial infection is a
known cause of hepatic dysfunction, and hyperbilirubi-
naemia often occurs with sepsis. After major surgery, bacte-
rial infection is a common complication that probably
increases the risk of hyperbilirubinaemia. Clinically, it is diffi-
cult to diagnose every case of postoperative bacterial infec-
tion reliably. For the purpose of the present study, which
used retrospective data, we arbitrarily defined infection
using broad criteria for assessing infection in the critically ill.
Wang et al [2] reported significantly higher mortality in
patients with postoperative hyperbilirubinaemia whose TB
levels peaked on POD 7 than in hyperbilirubinaemic
patients whose TB levels peaked on POD 1 or 2 [2]. They
did not present any explanation for why TB increased late
after operation. The present results suggest a possible
answer, however. In the patient sample studied, those with
bacterial infection showed peak TB levels on POD 11 in the
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Figure 1
(a) Course of TB, (b) CRP and (c) WBC in
each group [left column, C group (open-heart
surgery); right column, E group
(oesophagectomy)] after operation. Open
trianges show each parameter in the C group
patients without hyperbilirubinaemia (HYB),
and closed trigangles show each parameter
in the C group patients with
hyperbilirubinaemia. Open squares show
each parameter in the E group patients
without hyperbilirubinaemia, and closed
squares show each parameter in the E group


























































































C group and POD 5 in the E group; in addition, peak levels
were generally higher in patients classified as infected.
The majority of patients showed TB levels of greater than
2 mg/dl, and rates found in the present report were higher
than those reported elsewhere. Depending on the report,
the incidence of hyperbilirubinaemia varies greatly, from as
low as 3% to as high as 40%. These reports generally
cover a single week of postoperative observation. Follow-
ing the example of Ryan et al [7], we analyzed data from a
2-week period. Wang et al [2] also reported that hyper-
bilirubinaemia developed a couple of days after the opera-
tion, but it did not increase mortality, whereas the late
increase in TB was related to high mortality. Although the
long observation time was one of the reasons for high inci-
dence of hyperbilirubinaemia found in the present study,
the incidence did not change if we limited the observation
time from 2 weeks to 1 week. Consequently, the longer
period of observation could not explain the high rate of
hyperbilirubinaemia found in the present study. Operative
time is an important factor that correlates with postopera-
tive hyperbilirubinaemia, and the periods in the present
study were long. This may explain the high incidence of
hyperbilirubinaemia. The operative time in the report of
Wang et al [2] was 269 ± 6 min, which is a shorter opera-
tive period than for either the C (517 ± 25 min) or the E
(464 ± 19 min) group studied in the present study.
Wang et al [2] also reported mortality of 5.6% for patients
with postoperative hyperbilirubinaemia, whereas Collins et
al [8] reported a 25% mortality for similar patients. The
present sample shows a total mortality of 4.8%, with the
only fatalities occurring in the C group, in which 7.5% of
the patients died. The mortality of the patients with post-
operative hyperbilirubinaemia was 7.0% (C group, 12%;
E group, 0%). The association of postoperative hyper-
bilirubinaemia with higher postoperative morbidity and
mortality was noted. Our finding that high mortality is more
likely in patients who show delayed postoperative peak
hyperbilirubinaemia is comparable to the findings of Wang
et al [2]. The results of the present study suggest that
postoperative infection correlates with hyperbilirubinaemia
in the later postoperative period.
Collins et al [8] and Chu et al [9] reported that jaundice
after CPB was mainly a symptom of conjugated hyper-
bilirubinaemia, and have suggested that this is due to
failure to excrete bilirubin. In contrast, a report by Klepetko
http://ccforum.com/content/4/3/180
Figure 2
Patients with hyperbilirubinaemia were
divided into two subgroups according to the
existence of infection. (a) Course of TB, (b)
CRP and (c) WBC in subgroups of each
group [left column, C group (open-heart
surgery); right column, E group
(oesophagectomy)] after operation. Open
triangles show each parameter in the C
group patients without infection, and closed
triangles show each parameter in the C
group patients with infection. Open squares
show each parameter in the E group patients
without infection, and closed squares show
each parameter in the E group patients with
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and Miholic [10] suggests that postoperative hyperbilirubi-
naemia is mainly due to an increase in unconjugated biliru-
bin of haemolytic origin. These factors may influence the
development of hyperbilirubinaemia soon after open-heart
surgery with CPB. The rapid postoperative development
of hyperbilirubinaemia in patients in the E group is clearly
due to stress factors other than CPB.
Hyperbilirubinaemia after CPB has been considered to be
due to an increase in bilirubin load that results from haemol-
ysis, and researchers have been developing CPB tech-
niques to reduce the bilirubin load. Unconjugated bilirubin
was not the main factor in the hyperbilirubinaemia of the
C group patients in the present study. On the other hand,
the patients with postoperative hyperbilirubinaemia were
also those who received larger volumes of transfused blood,
so large loads of bilirubin are related to postoperative hyper-
bilirubinaemia. Fukusaki et al [11] reported that hypotension
and haemodilution during surgery results in worse postoper-
ative values for biological liver function tests and TB.
Patients who receive large volumes of transfused blood may
have episodes of hypotension and/or anaemia during
surgery, and this may be a cause of postoperative hyper-
bilirubinaemia. Hebert et al [12] reported high mortality for
critically ill patients who received large volumes of trans-
fused blood; the present results concur with this finding.
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Table 6
Duration of ICU stay
C group E group
Total 6.9 ± 1.1 8.5 ± 1.0
non-HYB 4.0 ± 0.3 5.8 ± 0.4*
HYB 9.6 ± 1.7† 10.1 ± 1.2†
Patients in group C were subjected to open-heart surgery; patients in
group E were subjected to oesophagectomy. Both groups were
divided into subgroups according to the existence of
hyperbilirubinaemia (HYB). Data are expressed as mean ± standard
error. *P < 0.05, versus patients in the C group; †P < 0.05, versus
patients without HYB.
Table 5
Effect of infection on the incidence of postoperative
hyperbilirubinaemia
C group E group
Noninfected Infected Noninfected Infected
n 101 32 33 41
non-HYB 63 (62) 2 (6) 21 (64) 6 (15)
Mortality 3 (3) 0 (0) 0 (0) 0 (0)
HYB 38 (38) 30 (94)* 12 (36) 35 (85)*
Mortality 1 (1) 7 (22)*† 0 (0) 0 (0)
Patients in group C were subjected to open-heart surgery; patients in
group E were subjected to oesophagectomy. Values are expressed as
number (percentage). *P < 0.05, versus patients without infection;
†P < 0.05, versus patients without hyperbilirubinaemia (HYB).
Table 4
Analysis of risk factors for postoperative hyperbilirubinaemia
C group E group
non-HYB HYB Non-HYB HYB
(n = 65) (n = 68) (n = 27) (n = 47)
Age (years) 58 ± 1.4 62 ± 1.3 57 ± 1.7 60 ± 1.1
Sex (male/female) 39/26 39/29 17/10 39/8
Operative time (min) 465 ± 24 571 ± 26* 415 ± 17 493 ± 20*
Transfusion (ml) 2000 ± 260 3426 ± 441* 277 ± 73 890 ± 201
Preoperative TB (mg/dl) 0.6 ± 0.03 0.9 ± 0.09* 0.7 ± 0.06 0.7 ± 0.04
Preoperative conjugated bilirubin (mg/dl) 0.2 ± 0.01 0.3 ± 0.03* 0.2 ± 0.02 0.2 ± 0.01
Preoperative alanine aminotransferase (IU/l) 18 ± 1.3 19 ± 2.5 15 ± 2.1 22 ± 3.1
Preoperative aspartate aminotransferase (IU/l) 16 ± 0.8 22 ± 2.9 16 ± 1.7 20 ± 1.9
Preoperative lactate dehydrogenase (IU/l) 274 ± 11.2 367 ± 45.6 231 ± 11.6 255 ± 17.0
Preoperative alkaline phosphatase (IU/l) 117 ± 5.5 128 ± 8.9 113 ± 7.1 121 ± 5.3
Hepatatis C virus positive 3 10 2 5
Preoperative HYP 0 2 0 0
Patients in group C were subjected to open-heart surgery; patients in group E were subjected to oesophagectomy. Data are expressed as mean ±
standard error. *P < 0.05, versus patients without hyperbilirubinaemia (HYB).
Finally, with regard to risk factors, Wang et al [2] reported
that patients with high preoperative levels of TB were
more likely to develop postoperative hyperbilirubinaemia.
We also found that patients in the C group who devel-
oped postoperative hyperbilirubinaemia had higher levels
of TB in blood samples taken before surgery.
In conclusion, after open-heart surgery and oesophagec-
tomy, the levels of serum TB in about half of the patients in
the present sample increased to hyperbilirubinaemic levels.
The operative time correlated well with the occurrence of
hyperbilirubinaemia. Infection significantly correlated with
both mortality and TB levels after open-heart surgery; early
diagnosis and control of infection is crucial to prevent
worsening hyperbilirubinaemia and associated mortality.
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